Involvement of SHV-12 and SHV-2a Encoding Plasmids in Outbreaks of Extended-Spectrum β-Lactamase-ProducingKlebsiella pneumoniaein a Tunisian Neonatal Ward
- 1 June 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 10 (2), 132-138
- https://doi.org/10.1089/1076629041310118
Abstract
Previous genotypic investigations of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae recovered in a Tunisian neonatal ward revealed the spread of two epidemic strains and a high number of genetically unrelated isolates. The aim of the present study was to determine the role of the dissemination of self-transferrable plasmids harboring bla genes in the outbreaks experienced by the ward. The 49 previously identified clinical isolates of ESBL-producing K. pneumoniae were examined for relationships between their enzymes and plasmids. Analysis of crude extracts by isoelectric focusing showed four β-lactamase-activities at pI 8.2, 7.6, 6, and 5.4. Clinical isolates contained large plasmids that could be transferred by conjugation and transformation conferring resistance to expanded-spectrum cephalosporins. DNA amplification and sequencing were performed to confirm the identities of transferred β-lactamases. Nucleotide sequence analysis of SHV-specific PCR products from six isolates identified two blaSHV genes corresponding to SHV derived ESBLs, SHV-12 and SHV-2a. PstI digestion of plasmid DNA from transformants revealed six restriction patterns. The occurrence of the prevalent plasmid pattern in both epidemic strains and unrelated isolates indicated that diffusion and endemic persistence of the blaSHV-ESBL genes in the ward were due to concomitant spread of epidemic strains and plasmid dissemination among unrelated strains.Keywords
This publication has 35 references indexed in Scilit:
- Molecular Characterization of Amoxicillin-Clavulanate Resistance in a Clinical Isolate ofEscherichia coliMicrobial Drug Resistance, 2002
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Are SHV β-Lactamases Universal in Klebsiella pneumoniae ? Antimicrobial Agents and Chemotherapy, 2000
- A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in JapanFEMS Microbiology Letters, 2000
- Concurrent outbreaks of extended-spectrum β-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospitalJournal of Antimicrobial Chemotherapy, 1999
- Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in tunisia caused by multiply drug resistantSalmonella wien producing SHV-2 beta-lactamaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Molecular characterization of a new plasmid-encoded SHV-type -lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniaeJournal of General Microbiology, 1991
- Two novel transferable extended-spectrum β-lactamases from Klebsiella pneumoniae in TunisiaFEMS Microbiology Letters, 1990
- Synergy between clavulanic acid and newer β-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmnella typhimurium resistant to third-generation cephalosporinsJournal of Antimicrobial Chemotherapy, 1988
- Detection of specific sequences among DNA fragments separated by gel electrophoresisJournal of Molecular Biology, 1975